An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive